Sign In
Buy PTI
$1.08
+0 (+0%)
At Close: Aug 17, 2022
Harness Therapeutics Appoints Seasoned Biopharmaceutical Leader, Ms. Meenu Chhabra Karson, as Board Chair
03:00am, Wednesday, 24'th Apr 2024
Ms. Chhabra Karson brings highly successful 20-year track record in industry leadership roles Cambridge, UK, April 24 2024: Harness Therapeutics, a biotechnology company focused on protein upregulatio
Noor Muqaddam: The high society beheading that stunned a nation
12:21am, Friday, 25'th Feb 2022 Kwhen Finance
Solve Industrial Motion Group Acquires Bearings Limited and Tritan Brand
01:00pm, Thursday, 16'th Dec 2021 Kwhen FinanceYumanity Therapeutics Sees Lead Candidate Interim Data From Early-Stage Parkinson's Study By Mid-2021
12:02pm, Wednesday, 10'th Feb 2021
Yumanity Therapeutics Inc (NASDAQ: YMTX) reported results from the Phase 1 single ascending dose study in 40-healthy volunteers, evaluating its lead candidate, YTX-7739, an SCD inhibitor, for the t
BOSTON, Dec. 22, 2020 /PRNewswire/ -- Proteostasis Therapeutics, Inc. ("Proteostasis") (Nasdaq: PTI) announced today that, based on the final vote count certified by the inspector of elections at its
Proteostasis Therapeutics Reports Third Quarter 2020 Financial Results
04:15pm, Monday, 16'th Nov 2020
BOSTON, Nov. 16, 2020 /PRNewswire/ -- Proteostasis Therapeutics, Inc. (Nasdaq:PTI), a clinical stage biopharmaceutical company, today announced financial results for the third quarter ended September
Nod to amend Essential Commodities Act, empowered panel to woo investors: Watch cabinet briefing highlights
02:33pm, Wednesday, 03'rd Jun 2020
The Union Cabinet Wednesday approved amendment to the six-a-and-half decade old Essential Commodities Act to deregulate food items, including cereals, pulses and onion, a move that will transform the
